Advancing Skin Absorption Testing: The MIVO® Technology Revolution
MIVO® technology revolutionizes skin absorption testing by…
Optimizing Oral Drug Delivery: Unlocking Bioavailability through Simultaneous Dissolution and Permeation Studies
This work explores a pioneering approach to oral drug…
PRESSURE Project: Preventing Therapy Resistance in Esophageal Cancer Treatment
PRESSURE, a Horizon Europe Marie Skłodowska-Curie Actions…
Redefining Disease Modeling: The Synergy of MIVO® Technology and Advanced 3D Cell Cultures
Combining 3D cell cultures with dynamic perfusion, MIVO®…
B2B Project: A Breakthrough in Understanding Spontaneous Breast Cancer Metastasis to the Bones
B2B, an EU-funded project coordinated by Silvia Scaglione…
Advancing Cancer Immunology: How MIVO® Organ-on-Chip Platform is Transforming Tumor-Immune Studies
MIVO® enables the real-time study of immune–tumor…
React4life in the GlycoNoVi project for the treatment of Norovirus infection.
GlycoNoVi, a Horizon Europe Marie Skłodowska-Curie Actions…
MIVO-HTS: A new micro-fluid platform for the development of new drugs.
MIVO-HTS platform is a multi-organ-on-chip emulating organs…
React4Life is one of the founding members of the Italian Society of Organ-on-Chip
The Italian Society of Organ-on-Chip (SIOoC) unites leading…
React4Life at the 20th Italian Edition of the L’Oréal-UNESCO Award “For Women in Science”
Silvia Scaglione, co-founder at React4life, presented MIVO,…
Advanced preclinical models: a new approach to immuno-oncology challenges
React4Life publishes a new study showcasing a dynamic 3D…
Silvia Scaglione Reaches the Final of the 2024 GammaDonna Award
Silvia Scaglione won the Women Startup Award while…